期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Hypertrophic cardiornyopathy: from gene defect to clinical disease 被引量:14
1
作者 man-weichung TATIANATSOUTSMAN CHRISTOPHERSEMSARIAN 《Cell Research》 SCIE CAS CSCD 2003年第1期9-20,共12页
Major advances have been made over the last decade in our understanding of the molecular basis ofseveral cardiac conditions. Hypertrophic cardiomyopathy (HCM) was the first cardiac disorder in whicha genetic basis was... Major advances have been made over the last decade in our understanding of the molecular basis ofseveral cardiac conditions. Hypertrophic cardiomyopathy (HCM) was the first cardiac disorder in whicha genetic basis was identified and as such, has acted as a paradigm for the study of an inherited cardiacdisorder. HCM can result in clinical symptoms ranging from no symptoms to severe heart failure andpremature sudden death. HCM is the commonest cause of sudden death in those aged less than 35 years,including competitive athletes. At least ten genes have now been identified, defects in which cause HCM.All of these genes encode proteins which comprise the basic contractile unit of the heart, i.e. the sarcomere.While much is now known about which genes cause disease and the various clinical presentations, very littleis known about how these gene defects cause disease, and what factors modify the expression of the mutantgenes. Studies in both cell culture and animal models of HCM are now beginning to shed light on thesignalling pathways involved in HCM, and the role of both environmental and genetic modifying factors.Understanding these mechanisms will ultimately improve our knowledge of the basic biology of heart musclefunction, and will therefore provide new avenues for treating cardiovascular disease in man. 展开更多
关键词 HYPERTROPHY CARDIOMYOPATHY GENE MUTATIONS SIGNALLING modifying factors.
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部